252 results on '"Lindkvist, B"'
Search Results
2. Early and/or immediately full caloric diet versus standard refeeding in mild acute pancreatitis: A randomized open-label trial
- Author
-
Lariño-Noia, J., Lindkvist, B., Iglesias-García, J., Seijo-Ríos, S., Iglesias-Canle, J., and Domínguez-Muñoz, J.E.
- Published
- 2014
- Full Text
- View/download PDF
3. The role of high fat diet in the development of complications of chronic pancreatitis
- Author
-
Castiñeira-Alvariño, M., Lindkvist, B., Luaces-Regueira, M., Iglesias-García, J., Lariño-Noia, J., Nieto-García, L., and Domínguez-Muñoz, J.E.
- Published
- 2013
- Full Text
- View/download PDF
4. ADVANCED DIAGNOSTIC OF BILE DUCT STRICTURES OF UNCERTAIN ETIOLOGY WITH COMBINED EUS-ERCP
- Author
-
Bényei, E., additional, Sadik, R., additional, Hedenström, P., additional, Lindkvist, B., additional, and Molinaro, A., additional
- Published
- 2022
- Full Text
- View/download PDF
5. RISK FACTORS FOR UNDERESTIMATION OF PATIENT PAIN IN OUTPATIENT COLONOSCOPY
- Author
-
Ryhlander, J., additional, Ringström, G., additional, Lindkvist, B., additional, and Hedenström, P., additional
- Published
- 2022
- Full Text
- View/download PDF
6. Flight Altitudes and Homing in Swifts Apus apus and House Martins Delichon urbica
- Author
-
Gustafson, T., Lindkvist, B., Gotborn, L., Gyllin, R., Magnusson, A., Nihlén, A., and Strid, C.
- Published
- 1985
- Full Text
- View/download PDF
7. An Altimeter for Birds and Its Use
- Author
-
Kristiansson, K., Lindkvist, B., and Gustafson, T.
- Published
- 1977
- Full Text
- View/download PDF
8. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
- Author
-
Ferrari, P, McKay, J D, Jenab, M, Brennan, P, Canzian, F, Vogel, U, Tjønneland, A, Overvad, K, Tolstrup, J S, Boutron-Ruault, M-C, Clavel-Chapelon, F, Morois, S, Kaaks, R, Boeing, H, Bergmann, M, Trichopoulou, A, Katsoulis, M, Trichopoulos, D, Krogh, V, Panico, S, Sacerdote, C, Palli, D, Tumino, R, Peeters, P H, van Gils, C H, Bueno-de-Mesquita, B, Vrieling, A, Lund, E, Hjartåker, A, Agudo, A, Suarez, L R, Arriola, L, Chirlaque, M-D, Ardanaz, E, Sánchez, M-J, Manjer, J, Lindkvist, B, Hallmans, G, Palmqvist, R, Allen, N, Key, T, Khaw, K-T, Slimani, N, Rinaldi, S, Romieu, I, Boffetta, P, Romaguera, D, Norat, T, and Riboli, E
- Published
- 2012
- Full Text
- View/download PDF
9. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Author
-
Grote, V. A., Rohrmann, S., Nieters, A., Dossus, L., Tjønneland, A., Halkjær, J., Overvad, K., Fagherazzi, G., Boutron-Ruault, M. C., Morois, S., Teucher, B., Becker, S., Sluik, D., Boeing, H., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., Pala, V., Tumino, R., Vineis, P., Panico, S., Rodríguez, L., Duell, E. J., Molina-Montes, E., Dorronsoro, M., Huerta, J. M., Ardanaz, E., Jeurnink, S. M., Beulens, J. W. J., Peeters, P. H. M., Sund, M., Ye, W., Lindkvist, B., Johansen, D., Khaw, K. T., Wareham, N., Allen, N., Crowe, F., Jenab, M., Romieu, I., Michaud, D. S., Riboli, E., Romaguera, D., Bueno-de-Mesquita, H. B., and Kaaks, R.
- Published
- 2011
- Full Text
- View/download PDF
10. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- Author
-
Schlesinger, S., Aleksandrova, K., Pischon, T., Jenab, M., Fedirko, V., Trepo, E., Overvad, K., Roswall, N., Tjønneland, A., Boutron-Ruault, M. C., Fagherazzi, G., Racine, A., Kaaks, R., Grote, V. A., Boeing, H., Trichopoulou, A., Pantzalis, M., Kritikou, M., Mattiello, A., Sieri, S., Sacerdote, C., Palli, D., Tumino, R., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Quirós, J. R., Zamora-Ros, R., Sánchez, M. J., Arriola, L., Ardanaz, E., Tormo, M. J., Nilsson, P., Lindkvist, B., Sund, M., Rolandsson, O., Khaw, K. T., Wareham, N., Travis, R. C., Riboli, E., and Nöthlings, U.
- Published
- 2013
- Full Text
- View/download PDF
11. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans
- Author
-
Fedirko, V., Lukanova, A., Bamia, C., Trichopolou, A., Trepo, E., Nöthlings, U., Schlesinger, S., Aleksandrova, K., Boffetta, P., Tjønneland, A., Johnsen, N. F., Overvad, K., Fagherazzi, G., Racine, A., Boutron-Ruault, M. C., Grote, V., Kaaks, R., Boeing, H., Naska, A., Adarakis, G., Valanou, E., Palli, D., Sieri, S., Tumino, R., Vineis, P., Panico, S., Bueno-de-Mesquita, H. B(as)., Siersema, P. D., Peeters, P. H., Weiderpass, E., Skeie, G., Engeset, D., Quirós, J. R., Zamora-Ros, R., Sánchez, M. J., Amiano, P., Huerta, J. M., Barricarte, A., Johansen, D., Lindkvist, B., Sund, M., Werner, M., Crowe, F., Khaw, K. T., Ferrari, P., Romieu, I., Chuang, S. C., Riboli, E., and Jenab, M.
- Published
- 2013
- Full Text
- View/download PDF
12. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition
- Author
-
Jeurnink, S. M., Büchner, F. L., Bueno-de-Mesquita, H. B., Siersema, P. D., Boshuizen, H. C., Numans, M. E., Dahm, C. C., Overvad, K., Tjnneland, A., Roswall, N., Clavel-Chapelon, F., Boutron-Ruault, M. C., Morois, S., Kaaks, R., Teucher, B., Boeing, H., Buijsse, B., Trichopoulou, A., Benetou, V., Zylis, D., Palli, D., Sieri, S., Vineis, P., Tumino, R., Panico, S., Ocké, M. C., Peeters, P. H.M., Skeie, G., Brustad, M., Lund, E., Sánchez-Cantalejo, E., Navarro, C., Amiano, P., Ardanaz, E., Ramón Quirós, J., Hallmans, G., Johansson, I., Lindkvist, B., Regnér, S., Khaw, K. T., Wareham, N., Key, T. J., Slimani, N., Norat, T., Vergnaud, A. C., Romaguera, D., and Gonzalez, C. A.
- Published
- 2012
- Full Text
- View/download PDF
13. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project
- Author
-
González, C. A., Megraud, F., Buissonniere, A., Lujan Barroso, L., Agudo, A., Duell, E. J., Boutron-Ruault, M. C., Clavel-Chapelon, F., Palli, D., Krogh, V., Mattiello, A., Tumino, R., Sacerdote, C., Quirós, J. R., Sanchez-Cantalejo, E., Navarro, C., Barricarte, A., Dorronsoro, M., Khaw, K.-T., Wareham, N., Allen, N. E., Tsilidis, K. K., Bas Bueno-de-Mesquita, H., Jeurnink, S. M., Numans, M. E., Peeters, P. H. M., Lagiou, P., Valanou, E., Trichopoulou, A., Kaaks, R., Lukanova-McGregor, A., Bergman, M. M., Boeing, H., Manjer, J., Lindkvist, B., Stenling, R., Hallmans, G., Mortensen, L. M., Overvad, K., Olsen, A., Tjonneland, A., Bakken, K., Dumeaux, V., Lund, E., Jenab, M., Romieu, I., Michaud, D., Mouw, T., Carneiro, F., Fenge, C., and Riboli, E.
- Published
- 2012
- Full Text
- View/download PDF
14. P–selectin mediates neutrophil rolling and recruitment in acute pancreatitis
- Author
-
Hartman, H., Abdulla, A., Awla, D., Lindkvist, B., Jeppsson, B., Thorlacius, H., and Regnér, S.
- Published
- 2012
- Full Text
- View/download PDF
15. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
- Author
-
Dominguez-Munoz, J.E., primary, Drewes, A.M., additional, Lindkvist, B., additional, Ewald, N., additional, Czakó, L., additional, Rosendahl, J., additional, Löhr, J.M., additional, Löhr, M., additional, Dominguez-Munoz, J.E., additional, Besselink, M., additional, Mayerle, J., additional, Lerch, M.M., additional, Akisik, F., additional, Kartalis, N., additional, Manfredi, R., additional, Iglesias-Garcia, J., additional, Haas, S.L., additional, Keller, J., additional, Boermeester, M.A., additional, Werner, J., additional, Dumonceau, J.M., additional, Fockens, P., additional, Drewes, A., additional, Cheyan, G.O., additional, Drenth, J.P., additional, Hardt, P., additional, de Madaria, E., additional, Gheorghe, C., additional, Lindgren, F., additional, Schneider, A., additional, Witt, H., additional, Bollen, T., additional, Boraschi, P., additional, Frøkjær, J.B., additional, Rudolf, S., additional, Bruno, M., additional, Dimcevski, G., additional, Giovannini, M., additional, Pukitis, A., additional, Petrone, M., additional, Oppong, K., additional, Ammori, B., additional, Friess, H., additional, Izbiki, J.R., additional, Ganeh, P., additional, Salvia, R., additional, Sauvanet, A., additional, Barbu, S., additional, Lyadov, V., additional, Deprez, P., additional, Gubergrits, N., additional, Okhlobystiy, A.V., additional, Arvanitakis, M., additional, Costamagna, G., additional, Pap, A., additional, Andersson, R., additional, Hauge, T., additional, McKay, C., additional, Regnér, S., additional, Dite, P., additional, Olesen, S.S., additional, Duggan, S., additional, Hopper, A., additional, Phillips, M., additional, Shvets, O., additional, Vujasinovic, M., additional, Czako, L., additional, Piemonti, L., additional, Kocher, H., additional, Rebours, V., additional, Stimac, D., additional, and Hegyi, P., additional
- Published
- 2020
- Full Text
- View/download PDF
16. Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer
- Author
-
Aleksandrova K, Boeing H, Nöthlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P, Trepo E, Westhpal S, Talita Duarte-Salles, Stepien M, Overvad K, Tjønneland A, Halkjaer J, Mc, Boutron-Ruault, Dossus L, Racine A, Lagiou P, Bamia C, Benetou V, Agnoli C, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita B, Ph, Peeters, It, Gram, Lund E, Weiderpass E, Jr, Quirós, Agudo A, Mj, Sánchez, Gavrila D, Barricarte A, Dorronsoro M, Ohlsson B, Lindkvist B, Johansson A, Sund M, Kt, Khaw, Wareham N, Rc, Travis, Riboli E, Pischon T, Aleksandrova, K, Boeing, H, N?thlings, U, Jenab, M, Fedirko, V, Kaaks, R, Lukanova, A, Trichopoulou, A, Trichopoulos, D, Boffetta, P, Trepo, E, Westhpal, S, Duarte Salles, T, Stepien, M, Overvad, K, Tj?nneland, A, Halkjaer, J, Boutron Ruault, Mc, Dossus, L, Racine, A, Lagiou, P, Bamia, C, Benetou, V, Agnoli, C, Palli, D, Panico, Salvatore, Tumino, R, Vineis, P, Bueno de Mesquita, B, Peeters, Ph, Gram, It, Lund, E, Weiderpass, E, Quir?s, Jr, Agudo, A, S?nchez, Mj, Gavrila, D, Barricarte, A, Dorronsoro, M, Ohlsson, B, Lindkvist, B, Johansson, A, Sund, M, Khaw, Kt, Wareham, N, Travis, Rc, Riboli, E, Pischon, T., Aleksandrova, K., Boeing, H., Nöthlings, U., Jenab, M., Fedirko, V., Kaaks, R., Lukanova, A., Trichopoulou, A., Trichopoulos, D., Boffetta, P., Trepo, E., Westhpal, S., Duarte-Salles, T., Stepien, M., Overvad, K., Tjønneland, A., Halkjær, J., Boutron-Ruault, M.-C., Dossus, L., Racine, A., Lagiou, P., Bamia, C., Benetou, V., Agnoli, C., Palli, D., Panico, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, B., Peeters, P.H., Gram, I.T., Lund, E., Weiderpass, E., Quirós, J.R., Agudo, A., Sánchez, M.-J., Gavrila, D., Barricarte, A., Dorronsoro, M., Ohlsson, B., Lindkvist, B., Johansson, A., Sund, M., Khaw, K.-T., Wareham, N., Travis, R.C., and Riboli, E.
- Subjects
metabolic disorder ,Adult ,Male ,Carcinoma, Hepatocellular ,INTERLEUKIN-6 ,Gastroenterology and Hepatology ,DISEASE ,COLORECTAL-CANCER ,LEPTIN ,ADIPONECTIN ,Risk Factors ,INJURY ,EPIDEMIOLOGY ,Humans ,Prospective Studies ,Aged ,Inflammation ,INSULIN-RESISTANCE ,Science & Technology ,Gastroenterology & Hepatology ,Incidence ,Liver Neoplasms ,1103 Clinical Sciences ,Middle Aged ,Biliary Tract Neoplasms ,liver carcinogenesis ,HEPATOCELLULAR-CARCINOMA RISK ,1101 Medical Biochemistry and Metabolomics ,Cardiovascular and Metabolic Diseases ,1107 Immunology ,OBESITY ,Case-Control Studies ,Female ,Life Sciences & Biomedicine ,Biomarkers - Abstract
Obesity and associated metabolic disorders have been implicated in liver carcinogenesis; however, there are little data on the role of obesity-related biomarkers on liver cancer risk. We studied prospectively the association of inflammatory and metabolic biomarkers with risks of hepatocellular carcinoma (HCC), intrahepatic bile duct (IBD), and gallbladder and biliary tract cancers outside of the liver (GBTC) in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Over an average of 7.7 years, 296 participants developed HCC (n=125), GBTC (n=137), or IBD (n=34). Using risk-set sampling, controls were selected in a 2:1 ratio and matched for recruitment center, age, sex, fasting status, and time of blood collection. Baseline serum concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), C-peptide, total high-molecular-weight (HMW) adiponectin, leptin, fetuin-a, and glutamatdehydrogenase (GLDH) were measured, and incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. After adjustment for lifestyle factors, diabetes, hepatitis infection, and adiposity measures, higher concentrations of CRP, IL-6, C-peptide, and non-HMW adiponectin were associated with higher risk of HCC (IRR per doubling of concentrations=1.22; 95% CI=1.02-1.46; P = 0.03; 1.90; 95% CI=1.30-2.77; P = 0.001; 2.25; 95% CI=1.43-3.54; P = 0.0005; and 2.09; 95% CI=1.19-3.67; P = 0.01, respectively). CRP was associated also with risk of GBTC (IRR=1.22; 95% CI=1.05-1.42; P = 0.01). GLDH was associated with risks of HCC (IRR=1.62; 95% CI=1.25-2.11; P = 0.0003) and IBD (IRR=10.5; 95% CI=2.20-50.90; P = 0.003). The continuous net reclassification index was 0.63 for CRP, IL-6, C-peptide, and non-HMW adiponectin and 0.46 for GLDH, indicating good predictive ability of these biomarkers. Conclusion: Elevated levels of biomarkers of inflammation and hyperinsulinemia are associated with a higher risk of HCC, independent of obesity and established liver cancer risk factors. © 2014 The Authors. Hepatology published by Wiley on behalf of the American Association for the Study of Liver Diseases.
- Published
- 2014
17. Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition
- Author
-
Duarte-Salles, T, Fedirko, V, Stepien, M, Trichopoulou, A, Bamia, C, Lagiou, P, Lukanova, A, Trepo, E, Overvad, K, Tjønneland, A, Halkjær, J, Boutron-Ruault, M-C, Racine, A, Cadeau, C, Kühn, T, Aleksandrova, K, Trichopoulos, D, Tsiotas, K, Boffetta, P, Palli, D, Pala, V, Tumino, R, Sacerdote, C, Panico, S, Bueno-De-Mesquita, HB, Dik, VK, Peeters, PH, Weiderpass, E, Torhild Gram, I, Hjartåker, A, Ramõn Quirõs, J, Fonseca-Nunes, A, Molina-Montes, E, Dorronsoro, M, Navarro Sanchez, C, Barricarte, A, Lindkvist, B, Sonestedt, E, Johansson, I, Wennberg, M, Khaw, K-T, Wareham, N, Travis, RC, Romieu, I, Riboli, E, Jenab, M, Duarte Salles, T, Fedirko, V, Stepien, M, Trichopoulou, A, Bamia, C, Lagiou, P, Lukanova, A, Trepo, E, Overvad, K, Tj?nneland, A, Halkjaer, J, Boutron Ruault, Mc, Racine, A, Cadeau, C, K?hn, T, Aleksandrova, K, Trichopoulos, D, Tsiotas, K, Boffetta, P, Palli, D, Pala, V, Tumino, R, Sacerdote, C, Panico, Salvatore, Bueno de Mesquita, Hb, Dik, Vk, Peeters, Ph, Weiderpass, E, Torhild Gram, I, Hjart?ker, A, Ram?n Quir?s, J, Fonseca Nunes, A, Molina Montes, E, Dorronsoro, M, Navarro Sanchez, C, Barricarte, A, Lindkvist, B, Sonestedt, E, Johansson, I, Wennberg, M, Khaw, Kt, Wareham, N, Travis, Rc, Romieu, I, Riboli, E, Jenab, M., Duarte-Salles, T., Fedirko, V., Stepien, M., Trichopoulou, A., Bamia, C., Lagiou, P., Lukanova, A., Trepo, E., Overvad, K., Tjønneland, A., Halkjær, J., Boutron-Ruault, M.-C., Racine, A., Cadeau, C., Kühn, T., Aleksandrova, K., Trichopoulos, D., Tsiotas, K., Boffetta, P., Palli, D., Pala, V., Tumino, R., Sacerdote, C., Panico, S., Bueno-De-Mesquita, H.B., Dik, V.K., Peeters, P.H., Weiderpass, E., Torhild Gram, I., Hjartåker, A., Ramõn Quirõs, J., Fonseca-Nunes, A., Molina-Montes, E., Dorronsoro, M., Navarro Sanchez, C., Barricarte, A., Lindkvist, B., Sonestedt, E., Johansson, I., Wennberg, M., Khaw, K.-T., Wareham, N., Travis, R.C., Romieu, I., and Riboli, E.
- Subjects
Adult ,Aged, 80 and over ,Male ,calcium ,Carcinoma, Hepatocellular ,Liver Neoplasms ,prospective cohort ,Nutritional Status ,hepatocellular carcinoma ,Middle Aged ,Prognosis ,Young Adult ,dairy product ,Risk Factors ,Case-Control Studies ,Humans ,Female ,Dairy Products ,Prospective Studies ,Aged ,Follow-Up Studies - Abstract
Intake of dairy products has been associated with risk of some cancers, but findings are often inconsistent and information on hepatocellular carcinoma (HCC) risk is limited, particularly from prospective settings. The aim of our study was to investigate the association between consumption of total and specific dairy products (milk/cheese/yogurt) and their components (calcium/vitamin D/fats/protein), with first incident HCC (Ncases = 191) in the European Prospective Investigation into Cancer and Nutrition cohort, including a nested case-control subset (Ncases = 122) with the assessment of hepatitis B virus/hepatitis C virus infections status, liver damage and circulating insulin-like growth factor (IGF)-I levels. For cohort analyses, multivariable-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CI). For nested case-control analyses, conditional logistic regression was used to calculate odds ratios and 95% CI. A total of 477,206 participants were followed-up for an average of 11 years (person-years follow-up = 5,415,385). In the cohort study, a significant positive HCC risk association was observed for total dairy products (highest vs. lowest tertile, HR = 1.66, 95% CI: 1.13-2.43; ptrend = 0.012), milk (HR = 1.51, 95% CI: 1.02-2.24; ptrend = 0.049), and cheese (HR = 1.56, 95% CI: 1.02-2.38; ptrend = 0.101), but not yogurt (HR = 0.94, 95% CI: 0.65-1.35). Dietary calcium, vitamin D, fat and protein from dairy sources were associated with increased HCC risk, whereas the same nutrients from nondairy sources showed inverse or null associations. In the nested case-control study, similar results were observed among hepatitis-free individuals. Results from this large prospective cohort study suggest that higher consumption of dairy products, particularly milk and cheese, may be associated with increased HCC risk. Validation of these findings in other populations is necessary. Potential biologic mechanisms require further exploration. What's New? Currently, the role of dairy product intake in the development of hepatocellular carcinoma (HCC) is unclear. Using detailed data from a large multi-centric prospective cohort, this study investigated the association between consumption of total and specific dairy products with first incident HCC. The study found that higher dairy product consumption, particularly milk and cheese, was associated with increased HCC risk. Dietary calcium, vitamin D, fat and protein did not explain the observed associations. However, higher circulating IGF-I levels may play a role. © 2014 UICC.
- Published
- 2013
18. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
- Author
-
Lohr, J. M., Dominguez-Munoz, E., Rosendahl, J., Besselink, M., Mayerle, J., Lerch, M. M., Haas, S., Akisik, F., Kartalis, N., Iglesias-Garcia, J., Keller, J., Boermeester, M., Werner, J., Dumonceau, J. -M., Fockens, P., Drewes, A., Ceyhan, G., Lindkvist, B., Drenth, J., Ewald, N., Hardt, P., Madaria, E., Witt, H., Schneider, A., Manfredi, Riccardo, Brondum, F. J., Rudolf, S., Bollen, T., Bruno, M., Dimcevski, G., Giovannini, M., Pukitis, A., Petrone, M., Oppong, K., Ammori, B., Izbiki, J. R., Ganeh, P., Salvia, R., Sauvanet, A., Barbu, S., Lyadov, V., Gubergrits, N., Okhlobystiy, A. V., Arvanitakis, M., Costamagna, Guido, Pap, A., Andersson, R., Hauge, T., Mckay, C., Regner, S., Dite, P., Olesen, S., Duggan, S., Hopper, A., Phillips, M., Shvets, O., Vujasinovic, M., Czako, L., Piemonti, L., Kocher, H., Rebours, V., Stimac, D., Hegyi, P., Gheorghe, C., Lindgren, F., Boraschi, P., Friess, H., Deprez, P., and Gastroenterology & Hepatology
- Subjects
endoscopic therapy ,Chronic pancreatitis ,Development and Evaluation ,Grading of Recommendations Assessment ,diabetes mellitus ,evidence-based ,guidelines ,pancreatic exocrine insufficiency ,medicine.medical_specialty ,Evidence-based practice ,macromolecular substances ,Review ,Review Article ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Journal Article ,Medicine ,Settore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA ,business.industry ,Pancreatic exocrine insufficiency ,medicine.disease ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Oncology ,030220 oncology & carcinogenesis ,Pancreatitis ,030211 gastroenterology & hepatology ,Develompent and Evaluation ,business - Abstract
Contains fulltext : 169869.pdf (Publisher’s version ) (Open Access) BACKGROUND: There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed these European guidelines using an evidence-based approach. METHODS: Twelve multidisciplinary review groups performed systematic literature reviews to answer 101 predefined clinical questions. Recommendations were graded using the Grading of Recommendations Assessment, Development and Evaluation system and the answers were assessed by the entire group in a Delphi process online. The review groups presented their recommendations during the 2015 annual meeting of United European Gastroenterology. At this one-day, interactive conference, relevant remarks were voiced and overall agreement on each recommendation was quantified using plenary voting (Test and Evaluation Directorate). After a final round of adjustments based on these comments, a draft version was sent out to external reviewers. RESULTS: The 101 recommendations covered 12 topics related to the clinical management of chronic pancreatitis: aetiology (working party (WP)1), diagnosis of chronic pancreatitis with imaging (WP2 and WP3), diagnosis of pancreatic exocrine insufficiency (WP4), surgery in chronic pancreatitis (WP5), medical therapy (WP6), endoscopic therapy (WP7), treatment of pancreatic pseudocysts (WP8), pancreatic pain (WP9), nutrition and malnutrition (WP10), diabetes mellitus (WP11) and the natural course of the disease and quality of life (WP12). Using the Grading of Recommendations Assessment, Development and Evaluation system, 70 of the 101 (70%) recommendations were rated as 'strong' and plenary voting revealed 'strong agreement' for 99 (98%) recommendations. CONCLUSIONS: The 2016 HaPanEU/United European Gastroenterology guidelines provide evidence-based recommendations concerning key aspects of the medical and surgical management of chronic pancreatitis based on current available evidence. These recommendations should serve as a reference standard for existing management of the disease and as a guide for future clinical research.
- Published
- 2017
19. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study
- Author
-
Huang, J. Zagai, U. Hallmans, G. Nyrén, O. Engstrand, L. Stolzenberg-Solomon, R. Duell, E.J. Overvad, K. Katzke, V.A. Kaaks, R. Jenab, M. Park, J.Y. Murillo, R. Trichopoulou, A. Lagiou, P. Bamia, C. Bradbury, K.E. Riboli, E. Aune, D. Tsilidis, K.K. Capellá, G. Agudo, A. Krogh, V. Palli, D. Panico, S. Weiderpass, E. Tjønneland, A. Olsen, A. Martínez, B. Redondo-Sanchez, D. Chirlaque, M.-D. HM Peeters, P. Regnér, S. Lindkvist, B. Naccarati, A. Ardanaz, E. Larrañaga, N. Boutron-Ruault, M.-C. Rebours, V. Barré, A. Bueno-de-Mesquita, H.B. Ye, W.
- Abstract
The association between H. pylori infection and pancreatic cancer risk remains controversial. We conducted a nested case-control study with 448 pancreatic cancer cases and their individually matched control subjects, based on the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, to determine whether there was an altered pancreatic cancer risk associated with H. pylori infection and chronic corpus atrophic gastritis. Conditional logistic regression models were applied to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs), adjusted for matching factors and other potential confounders. Our results showed that pancreatic cancer risk was neither associated with H. pylori seropositivity (OR = 0.96; 95% CI: 0.70, 1.31) nor CagA seropositivity (OR = 1.07; 95% CI: 0.77, 1.48). We also did not find any excess risk among individuals seropositive for H. pylori but seronegative for CagA, compared with the group seronegative for both antibodies (OR = 0.94; 95% CI: 0.63, 1.38). However, we found that chronic corpus atrophic gastritis was non-significantly associated with an increased pancreatic cancer risk (OR = 1.35; 95% CI: 0.77, 2.37), and although based on small numbers, the excess risk was particularly marked among individuals seronegative for both H. pylori and CagA (OR = 5.66; 95% CI: 1.59, 20.19, p value for interaction < 0.01). Our findings provided evidence supporting the null association between H. pylori infection and pancreatic cancer risk in western European populations. However, the suggested association between chronic corpus atrophic gastritis and pancreatic cancer risk warrants independent verification in future studies, and, if confirmed, further studies on the underlying mechanisms. © 2016 UICC
- Published
- 2017
20. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort
- Author
-
Schlesinger, S, Aleksandrova, K, Pischon, T, Fedirko, V, Jenab, M, Trepo, E, Boffetta, P, Dahm, CC, Overvad, K, Tjønneland, A, Halkjær, J, Fagherazzi, G, Boutron-Ruault, MC, Carbonnel, F, Kaaks, R, Lukanova, A, Boeing, H, Trichopoulou, A, Bamia, C, Lagiou, P, Palli, D, Grioni, S, Panico, S, Tumino, R, Vineis, P, Hb, BDM, Van Den Berg, S, Peeters, PHM, Braaten, T, Weiderpass, E, Quirós, JR, Travier, N, Sánchez, MJ, Navarro, C, Barricarte, A, Dorronsoro, M, Lindkvist, B, Regner, S, Werner, M, Sund, M, Khaw, KT, Wareham, N, Travis, RC, Norat, T, Wark, PA, Riboli, E, Nöthlings, U, Schlesinger, S, Aleksandrova, K, Pischon, T, Fedirko, V, Jenab, M, Trepo, E, Boffetta, P, Dahm, Cc, Overvad, K, Tj?nneland, A, Halkj?r, J, Fagherazzi, G, Boutron Ruault, Mc, Carbonnel, F, Kaaks, R, Lukanova, A, Boeing, H, Trichopoulou, A, Bamia, C, Lagiou, P, Palli, D, Grioni, S, Panico, Salvatore, Tumino, R, Vineis, P, Bueno de Mesquita, Hb, van den Berg, S, Peeters, Ph, Braaten, T, Weiderpass, E, Quir?s, Jr, Travier, N, S?nchez, Mj, Navarro, C, Barricarte, A, Dorronsoro, M, Lindkvist, B, Regner, S, Werner, M, Sund, M, Khaw, Kt, Wareham, N, Travis, Rc, Norat, T, Wark, Pa, Riboli, E, N?thlings, U., Schlesinger, S., Aleksandrova, K., Pischon, T., Fedirko, V., Jenab, M., Trepo, E., Boffetta, P., Dahm, C.C., Overvad, K., Tjønneland, A., Halkjær, J., Fagherazzi, G., Boutron-Ruault, M.-C., Carbonnel, F., Kaaks, R., Lukanova, A., Boeing, H., Trichopoulou, A., Bamia, C., Lagiou, P., Palli, D., Grioni, S., Panico, S., Tumino, R., Vineis, P., Hb, B.-D.-M., Van Den Berg, S., Peeters, P.H.M., Braaten, T., Weiderpass, E., Quirós, J.R., Travier, N., Sánchez, M.-J., Navarro, C., Barricarte, A., Dorronsoro, M., Lindkvist, B., Regner, S., Werner, M., Sund, M., Khaw, K.-T., Wareham, N., Travis, R.C., Norat, T., Wark, P.A., Riboli, E., Nöthlings, U., International Prevention Research Institute (IPRI), The Tisch Cancer Institute, and Icahn School of Medicine at Mount Sinai [New York] (MSSM)
- Subjects
Male ,Cancer Research ,obesity ,Weight Gain ,Gastroenterology ,Body Mass Index ,Hepatocellular/*epidemiology/etiology Case-Control Studies Europe/epidemiology Female Hepatitis B/epidemiology Hepatitis C/epidemiology Humans Liver Neoplasms/*epidemiology/etiology Male Middle Aged Nutritional Status Obesity ,Biliary Tract Neoplasms/*epidemiology/etiology Body Composition Body Mass Index Body Weight Carcinoma ,hepatocellular carcinoma (HCC) ,0302 clinical medicine ,Waist–hip ratio ,intrahepatic (IBDC) ,Prospective Studies ,Prospective cohort study ,Abdominal/*epidemiology Proportional Hazards Models Prospective Studies Waist-Hip Ratio *Weight Gain ,Abdominal obesity ,extrahepatic bile duct system cancer ,2. Zero hunger ,Liver Neoplasms ,weight gain ,Middle Aged ,Hepatitis B ,Hepatitis C ,3. Good health ,European Prospective Investigation into Cancer and Nutrition ,Europe ,Biliary Tract Neoplasms ,Oncology ,030220 oncology & carcinogenesis ,Obesity, Abdominal ,Body Composition ,030211 gastroenterology & hepatology ,Female ,medicine.symptom ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,adulthood ,liver and biliary tract cancer ,Nutritional Status ,abdominal obesity ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Gallbladder cancer ,Proportional Hazards Models ,business.industry ,Waist-Hip Ratio ,Weight change ,Body Weight ,medicine.disease ,Endocrinology ,Relative risk ,Case-Control Studies ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,Body mass index - Abstract
Schlesinger, Sabrina Aleksandrova, Krasimira Pischon, Tobias Fedirko, Veronika Jenab, Mazda Trepo, Elisabeth Boffetta, Paolo Dahm, Christina C Overvad, Kim Tjonneland, Anne Halkjaer, Jytte Fagherazzi, Guy Boutron-Ruault, Marie-Christine Carbonnel, Franck Kaaks, Rudolf Lukanova, Annekatrin Boeing, Heiner Trichopoulou, Antonia Bamia, Christina Lagiou, Pagona Palli, Domenico Grioni, Sara Panico, Salvatore Tumino, Rosario Vineis, Paolo Bueno-de-Mesquita, H B van den Berg, Saskia Peeters, Petra H M Braaten, Tonje Weiderpass, Elisabete Quiros, J Ramon Travier, Noemie Sanchez, Maria-Jose Navarro, Carmen Barricarte, Aurelio Dorronsoro, Miren Lindkvist, Bjorn Regner, Sara Werner, Marten Sund, Malin Khaw, Kay-Tee Wareham, Nicholas Travis, Ruth C Norat, Teresa Wark, Petra A Riboli, Elio Nothlings, Ute eng 11692/Cancer Research UK/United Kingdom G0401527/Medical Research Council/United Kingdom G1000143/Medical Research Council/United Kingdom MC_U106179471/Medical Research Council/United Kingdom British Heart Foundation/United Kingdom Cancer Research UK/United Kingdom Department of Health/United Kingdom Medical Research Council/United Kingdom Wellcome Trust/United Kingdom Research Support, Non-U.S. Gov't 2012/05/24 06:00 Int J Cancer. 2013 Feb 1;132(3):645-57. doi: 10.1002/ijc.27645. Epub 2012 Jun 13.; International audience; General obesity has been positively associated with risk of liver and probably with biliary tract cancer, but little is known about abdominal obesity or weight gain during adulthood. We used multivariable Cox proportional hazard models to investigate associations between weight, body mass index, waist and hip circumference, waist-to-hip and waist-to-height ratio (WHtR), weight change during adulthood and risk of hepatocellular carcinoma (HCC), intrahepatic (IBDC) and extrahepatic bile duct system cancer [EBDSC including gallbladder cancer (GBC)] among 359,525 men and women in the European Prospective Investigation into Cancer and Nutrition study. Hepatitis B and C virus status was measured in a nested case-control subset. During a mean follow-up of 8.6 years, 177 cases of HCC, 58 cases of IBDC and 210 cases of EBDSC, including 76 cases of GBC, occurred. All anthropometric measures were positively associated with risk of HCC and GBC. WHtR showed the strongest association with HCC [relative risk (RR) comparing extreme tertiles 3.51, 95% confidence interval (95% CI): 2.09-5.87; p(trend) < 0.0001] and with GBC (RR: 1.56, 95% CI: 1.12-2.16 for an increment of one unit in WHtR). Weight gain during adulthood was also positively associated with HCC when comparing extreme tertiles (RR: 2.48, 95% CI: 1.49-4.13
- Published
- 2013
21. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
- Author
-
Löhr, M., Dominguez-Munoz, J.E., Besselink, M., Mayerle, J., Rosendahl, J., Lerch, M.M., Akisik, F., Kartalis, N., Manfredi, R., Iglesias-Garcia, J., Haas, S.L., Keller, J., Boermeester, M.A., Werner, J., Dumonceau, J.M., Fockens, P., Drewes, A., Cheyan, G.O., Lindkvist, B., Drenth, J.P., Ewald, N., Hardt, P., de Madaria, E., Gheorghe, C., Lindgren, F., Schneider, A., Witt, H., Bollen, T., Boraschi, P., Frøkjær, J.B., Rudolf, S., Bruno, M., Dimcevski, G., Giovannini, M., Pukitis, A., Petrone, M., Oppong, K., Ammori, B., Friess, H., Izbiki, J.R., Ganeh, P., Salvia, R., Sauvanet, A., Barbu, S., Lyadov, V., Deprez, P., Gubergrits, N., Okhlobystiy, A.V., Arvanitakis, M., Costamagna, G., Pap, A., Andersson, R., Hauge, T., McKay, C., Regnér, S., Dite, P., Olesen, S.S., Duggan, S., Hopper, A., Phillips, M., Shvets, O., Vujasinovic, M., Czako, L., Piemonti, L., Kocher, H., Rebours, V., Stimac, D., Hegyi, P., Drewes, A.M., Czakó, L., and Löhr, J.M.
- Published
- 2020
- Full Text
- View/download PDF
22. Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study
- Author
-
Zamora Ros R, Luj?n Barroso L, Bueno de Mesquita HB, Dik VK, Boeing H, Steffen A, Tj?nneland A, Olsen A, Bech BH, Overvad K, Boutron Ruault MC, Racine A, Fagherazzi G, Kuhn T, Katzke V, Trichopoulou A, Lagiou P, Trichopoulos D, Tumino R, Vineis P, Grioni S, Palli D, Weiderpass E, Skeie G, Huerta JM, S?nchez MJ, Arg?elles M, Amiano P, Ardanaz E, Nilsson L, Wallner B, Lindkvist B, Wallstr?m P, Peeters PH, Key TJ, Khaw KT, Wareham NJ, Freisling H, Stepien M, Ferrari P, Gunter MJ, Murphy N, Riboli E, Gonz?lez CA, PANICO, SALVATORE, Zamora Ros, R, Luj?n Barroso, L, Bueno de Mesquita, Hb, Dik, Vk, Boeing, H, Steffen, A, Tj?nneland, A, Olsen, A, Bech, Bh, Overvad, K, Boutron Ruault, Mc, Racine, A, Fagherazzi, G, Kuhn, T, Katzke, V, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Tumino, R, Panico, Salvatore, Vineis, P, Grioni, S, Palli, D, Weiderpass, E, Skeie, G, Huerta, Jm, S?nchez, Mj, Arg?elles, M, Amiano, P, Ardanaz, E, Nilsson, L, Wallner, B, Lindkvist, B, Wallstr?m, P, Peeters, Ph, Key, Tj, Khaw, Kt, Wareham, Nj, Freisling, H, Stepien, M, Ferrari, P, Gunter, Mj, Murphy, N, Riboli, E, and Gonz?lez, Ca
- Subjects
Cohort Studies ,Europe ,Male ,Risk ,Esophageal Neoplasms ,Tea ,Smoking ,Humans ,Female ,Prospective Studies ,Middle Aged ,Coffee - Abstract
Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer (EC) is still inconclusive. We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition. Tea and coffee intakes were recorded using country-specific validated dietary questionnaires. Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk. During a mean follow-up of 11.1 years, 339 participants developed EC, of which 142 were esophageal adenocarcinoma (EAC) and 174 were esophageal squamous cell carcinoma (ESCC). In the multivariable models, no significant associations between tea (mostly black tea), and coffee intake and risk of EC, EAC and ESCC were observed. In stratified analyses, among men coffee consumption was inversely related to ESCC (HR for comparison of extreme tertiles 0.42, 95% CI 0.20-0.88; p-trend=0.022), but not among women. In current smokers, a significant and inverse association was observed between ESCC risk and tea (HR 0.46, 95% CI 0.23-0.93; p-trend=0.053) and coffee consumption (HR 0.37, 95% CI 0.19-0.73; p-trend=0.011). However, no statistically significant findings were observed using the continuous variable (per 100 mL/d). These data did not show a significant association between tea and coffee consumption and EC, EAC and ESCC, although a decreased risk of ESCC among men and current smokers is suggested, but need to be confirmed in further prospective studies including more cases. What's new? Tea and coffee, because of their high polyphenol content, may help reduce the risk of esophageal cancer (EC), but data across multiple studies have been inconsistent. In this cohort study of men and women from nine European countries, no significant association was found between coffee and tea consumption and overall risk of EC and its subtypes. Among current smokers or men, an inverse association with esophageal squamous cell carcinoma was suggested, although further prospective studies are needed to confirm the potential relationship. © 2014 UICC.
- Published
- 2014
23. Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations
- Author
-
Durães, C, Muñoz, X, Bonet, C, García, N, Venceslá, A, Carneiro, F, Peleteiro, B, Lunet, N, Barros, H, Lindkvist, B, Boutron-Ruault, M, Bueno-de-Mesquita, H, Rizzato, C, Trichopoulou, A, Weiderpass, E, Naccarati, A, Travis, R, Tjønneland, A, Gurrea, AB, Johansson, M, Riboli, E, Figueiredo, C, González, C, Capellà, G, and Machado, J
- Abstract
The most studied genetic susceptibility factors involved in gastric carcinoma (GC) risk are polymorphisms in the inflammation-linked genes interleukin 1 (IL1) B and IL1RN. Despite the evidence pointing to the IL1 region, definite functional variants reproducible across populations of different genetic background have not been discovered so far. A high density linkage disequilibrium (LD) map of the IL1 gene cluster was established using HapMap to identify haplotype tagSNPs. Eighty-seven SNPs were genotyped in a Portuguese case-control study (358 cases, 1,485 controls) for the discovery analysis. A replication study, including a subset of those tagSNPs (43), was performed in an independent analysis (EPIC-EurGast) containing individuals from 10 European countries (365 cases, 1284 controls). Single SNP and haplotype block associations were determined for GC overall and anatomopathological subtypes. The most robust association was observed for SNP rs17042407, 16Kb upstream of the IL1A gene. Although several other SNP associations were observed, only the inverse association of rs17042407 allele C with GC of the intestinal type was observed in both studies, retaining significance after multiple testing correction (p=0.0042) in the combined analysis. The haplotype analysis of the IL1A LD block in the combined dataset revealed the association between a common haplotype carrying the rs17042407 variant and GC, particularly of the intestinal type (p=3.1 × 10-5) and non cardia localisation (p=4.6 × 10-3). These results confirm the association of IL1 gene variants with GC and reveal a novel SNP and haplotypes in the IL1A region associated with intestinal type GC in European populations. What's new? Genetic susceptibility to gastric cancer lurks in the region of the interleukin 1 gene cluster, but no one yet knows just how genetic variation contributes to risk. These authors searched for other variants within this genetic neighborhood by assessing linkage disequilibrium. There they found several small nucleotide polymorphisms (SNPs), mainly in the IL1A gene region, that associated with gastric carcinoma, particularly the intestinal subtype. By identifying these SNPs, they hope to shed more light on how the disease develops or help identify people who are at risk. © 2014 UICC.
- Published
- 2016
24. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort
- Author
-
Companioni, O, Bonet, C, Muñoz, X, Weiderpass, E, Panico, S, Tumino, R, Palli, D, Agnoli, C, Vineis, P, Boutron-Ruault, M, Racine, A, Clavel-Chapelon, F, Travis, R, Khaw, K, Riboli, E, Murphy, N, Vergnaud, A, Trichopoulou, A, Benetou, V, Trichopoulos, D, Lund, E, Johansen, D, Lindkvist, B, Johansson, M, and Sund, M
- Abstract
Helicobacter pylori is a recognized causal factor of noncardia gastric cancer (GC). Lipopolysaccharide and peptidoglycan of this bacterium are recognized by CD14, TLR4 and NOD2 human proteins, while NFKB1 activates the transcription of pro-inflammatory cytokines to elicit an immune response. Single nucleotide polymorphisms (SNPs) in these genes have been associated with GC in different populations. We genotyped 30 SNPs of these genes, in 365 gastric adenocarcinomas and 1,284 matched controls from the European Prospective Investigation into Cancer cohort. The association with GC and its histological and anatomical subtypes was analyzed by logistic regression and corrected for multiple comparisons. Using a log-additive model, we found a significant association between SNPs in CD14, NOD2 and TLR4 with GC risk. However, after applying the multiple comparisons tests only the NOD2 region remained significant (p = 0.009). Analysis according to anatomical subtypes revealed NOD2 and NFKB1 SNPs associated with noncardia GC and CD14 SNPs associated with cardia GC, while analysis according to histological subtypes showed that CD14 was associated with intestinal but not diffuse GC. The multiple comparisons tests confirmed the association of NOD2 with noncardia GC (p = 0.0003) and CD14 with cardia GC (p = 0.01). Haplotype analysis was in agreement with single SNP results for NOD2 and CD14 genes. From these results, we conclude that genetic variation in NOD2 associates with noncardia GC while variation in CD14 is associated with cardia GC.
- Published
- 2016
25. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European prospective investigation into cancer-eurgast cohort
- Author
-
Companioni O, Bonet C, Mu?oz X, Weiderpass E, Tumino R, Palli D, Agnoli C, Vineis P, Boutron Ruault MC, Racine A, Clavel Chapelon F, Travis RC, Khaw KT, Riboli E, Murphy N, Vergnaud AC, Trichopoulou A, Benetou V, Trichopoulos D, Lund E, Johansen D, Lindkvist B, Johansson M, Sund M, Ardanaz E, S?nchez Cantalejo E, Huerta JM, Dorronsoro M, Ram?n Quir?s J, Tjonneland A, Mortensen LM, Overvad K, Chang Claude J, Rizzato C, Boeing H, de Mesquita HB, Siersema P, Peeters PH, Numans ME, Carneiro F, Licaj I, Freisling H, Sala N, Gonz?lez CA, PANICO, SALVATORE, Companioni, O, Bonet, C, Mu?oz, X, Weiderpass, E, Panico, Salvatore, Tumino, R, Palli, D, Agnoli, C, Vineis, P, Boutron Ruault, Mc, Racine, A, Clavel Chapelon, F, Travis, Rc, Khaw, Kt, Riboli, E, Murphy, N, Vergnaud, Ac, Trichopoulou, A, Benetou, V, Trichopoulos, D, Lund, E, Johansen, D, Lindkvist, B, Johansson, M, Sund, M, Ardanaz, E, S?nchez Cantalejo, E, Huerta, Jm, Dorronsoro, M, Ram?n Quir?s, J, Tjonneland, A, Mortensen, Lm, Overvad, K, Chang Claude, J, Rizzato, C, Boeing, H, de Mesquita, Hb, Siersema, P, Peeters, Ph, Numans, Me, Carneiro, F, Licaj, I, Freisling, H, Sala, N, and Gonz?lez, Ca
- Subjects
digestive system diseases - Abstract
Helicobacter pylori is a recognized causal factor of noncardia gastric cancer (GC). Lipopolysaccharide and peptidoglycan of this bacterium are recognized by CD14, TLR4 and NOD2 human proteins, while NFKB1 activates the transcription of pro-inflammatory cytokines to elicit an immune response. Single nucleotide polymorphisms (SNPs) in these genes have been associated with GC in different populations. We genotyped 30 SNPs of these genes, in 365 gastric adenocarcinomas and 1,284 matched controls from the European Prospective Investigation into Cancer cohort. The association with GC and its histological and anatomical subtypes was analyzed by logistic regression and corrected for multiple comparisons. Using a log-additive model, we found a significant association between SNPs in CD14, NOD2 and TLR4 with GC risk. However, after applying the multiple comparisons tests only the NOD2 region remained significant (p = 0.009). Analysis according to anatomical subtypes revealed NOD2 and NFKB1 SNPs associated with noncardia GC and CD14 SNPs associated with cardia GC, while analysis according to histological subtypes showed that CD14 was associated with intestinal but not diffuse GC. The multiple comparisons tests confirmed the association of NOD2 with noncardia GC (p = 0.0003) and CD14 with cardia GC (p = 0.01). Haplotype analysis was in agreement with single SNP results for NOD2 and CD14 genes. From these results, we conclude that genetic variation in NOD2 associates with noncardia GC while variation in CD14 is associated with cardia GC.
- Published
- 2014
26. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
- Author
-
Lukanova, A, Becker, S, Hüsing, A, Schock, H, Fedirko, V, Trepo, E, Trichopoulou, A, Bamia, C, Lagiou, P, Benetou, V, Trichopoulos, D, Nöthlings, U, Tjønneland, A, Overvad, K, Dossus, L, Teucher, B, Boeing, H, Aleksandrova, K, Palli, D, Pala, V, Panico, S, Tumino, R, Ricceri, F, Bueno-de-Mesquita, HB, Siersema, PD, Peeters, PH, Quiros, JR, Duell, EJ, Molina-Montes, E, Chirlaque, MD, Gurrea, AB, Dorronsoro, M, Lindkvist, B, Johansen, D, Werner, M, Sund, M, Khaw, KT, Wareham, N, Key, TJ, Travis, RC, Rinaldi, S, Romieu, I, Gunter, MJ, Riboli, E, Jenab, M, Kaaks, R, Lukanova, A, Becker, S, H?sing, A, Schock, H, Fedirko, V, Trepo, E, Trichopoulou, A, Bamia, C, Lagiou, P, Benetou, V, Trichopoulos, D, N?thlings, U, Tj?nneland, A, Overvad, K, Dossus, L, Teucher, B, Boeing, H, Aleksandrova, K, Palli, D, Pala, V, Panico, Salvatore, Tumino, R, Ricceri, F, Bueno de Mesquita, Hb, Siersema, Pd, Peeters, Ph, Quiros, Jr, Duell, Ej, Molina Montes, E, Chirlaque, Md, Gurrea, Ab, Dorronsoro, M, Lindkvist, B, Johansen, D, Werner, M, Sund, M, Khaw, Kt, Wareham, N, Key, Tj, Travis, Rc, Rinaldi, S, Romieu, I, Gunter, Mj, Riboli, E, Jenab, M, and Kaaks, R.
- Subjects
Aged, 80 and over ,Male ,Carcinoma, Hepatocellular ,Liver Neoplasms ,Enzyme-Linked Immunosorbent Assay ,Middle Aged ,ROC Curve ,Risk Factors ,Area Under Curve ,Case-Control Studies ,Sex Hormone-Binding Globulin ,Biomarkers, Tumor ,Humans ,Female ,Testosterone ,Insulin-Like Growth Factor I ,Aged - Abstract
Elevated pre-diagnostic testosterone and insulin-like growth factor-I (IGF-I) concentrations have been proposed to increase risk of hepatocellular carcinoma (HCC). However, the metabolism of these hormones is altered as a consequence of liver damage and they may have clinical utility as HCC risk markers. A case-control study was nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and included 125 incident HCC cases and 247 individually matched controls. Testosterone, sex hormone binding globulin (SHBG) and IGF-I were analyzed by immunoassays. Odds ratios (OR) and 95% confidence intervals (CI) were estimated by conditional logistic regression. The area under the receiver operating curves (AUC) was calculated to assess HCC predictive ability of the tested models. After adjustments for epidemiological variables (body mass index, smoking, ethanol intake, hepatitis and diabetes) and liver damage (a score based on albumin, bilirubin, aspartate aminotransaminase, alanine aminotransaminase, gamma-glutamyltransferase and alkaline phosphatase concentrations), only SHBG remained significantly associated with risk (OR for top versus bottom tertile of 3.86 (1.32-11.3), ptrend =0.009). As a single factor SHBG had an AUC of 0.81 (0.75-0.86). A small, but significant increase in AUC was observed when SHBG was added to a model including the liver damage score and epidemiological variables (from 0.89 to 0.91, p=0.02) and a net reclassification of 0.47% (0.45-0.48). The observed associations of HCC with pre-diagnostic SHBG, free testosterone and IGF-I concentrations are in directions opposite to that expected under the etiological hypotheses. SHBG has a potential to be tested as pre-diagnostic risk marker for HCC. © 2013 Wiley Periodicals, Inc.
- Published
- 2014
27. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study
- Author
-
Fedirko V, Talita Duarte-Salles, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, Trepo E, Tjønneland A, Olsen A, Overvad K, Mc, Boutron-Ruault, Clavel-Chapelon F, Kvaskoff M, Kühn T, Lukanova A, Boeing H, Buijsse B, Klinaki E, Tsimakidi C, Naccarati A, Tagliabue G, Panico S, Tumino R, Palli D, Hb, Bueno-De-Mesquita, Pd, Siersema, Ph, Peters, Lund E, Brustad M, Ks, Olsen, Weiderpass E, Zamora-Ros R, Mj, Sánchez, Ardanaz E, Amiano P, Navarro C, Jr, Quirós, Werner M, Sund M, Lindkvist B, Malm J, Rc, Travis, Kt, Khaw, Stepien M, Scalbert A, Romieu I, Lagiou P, Riboli E, Jenab M, Fedirko, V, Duarte Salles, T, Bamia, C, Trichopoulou, A, Aleksandrova, K, Trichopoulos, D, Trepo, E, Tj?nneland, A, Olsen, A, Overvad, K, Boutron Ruault, Mc, Clavel Chapelon, F, Kvaskoff, M, K?hn, T, Lukanova, A, Boeing, H, Buijsse, B, Klinaki, E, Tsimakidi, C, Naccarati, A, Tagliabue, G, Panico, Salvatore, Tumino, R, Palli, D, Bueno de Mesquita, Hb, Siersema, Pd, Peters, Ph, Lund, E, Brustad, M, Olsen, K, Weiderpass, E, Zamora Ros, R, S?nchez, Mj, Ardanaz, E, Amiano, P, Navarro, C, Quir?s, Jr, Werner, M, Sund, M, Lindkvist, B, Malm, J, Travis, Rc, Khaw, Kt, Stepien, M, Scalbert, A, Romieu, I, Lagiou, P, Riboli, E, and Jenab, M.
- Subjects
Male ,Carcinoma, Hepatocellular ,Incidence ,Liver Neoplasms ,Middle Aged ,Europe ,Risk Factors ,Case-Control Studies ,Multivariate Analysis ,Humans ,Female ,Prospective Studies ,Vitamin D ,Biomarkers ,Aged ,Retrospective Studies - Abstract
The association between vitamin D status and hepatocellular carcinoma has not been well investigated, despite experimental evidence supporting an important role of vitamin D in liver pathophysiology. Our objective was to investigate the association between pre-diagnostic circulating 25-hydroxyvitamin D [25(OH)D] serum levels and risk of hepatocellular carcinoma in a prospective, nested case-control study among 520,000 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Each case (n = 138) diagnosed between 1992 and 2010 was matched to one control by age, sex, study center, date and time of blood collection, and fasting status. Serum baseline levels of 25(OH)D were measured by liquid chromatography/tandem mass spectrometry. Multivariable incident rate ratios (IRR) of hepatocellular carcinoma associated with continuous (per 10 nmol/L) or categorical levels (tertiles or a priori-defined categories) of pre-diagnostic 25(OH)D. Higher 25(OH)D levels were associated with a 49% reduction in the risk of hepatocellular carcinoma (highest vs. lowest tertile: multivariable IRR = 0.51, 95% confidence interval, 0.26 to 0.99; Ptrend = 0.04; per 10 nmol/L increase: IRR = 0.80, 95% confidence interval, 0.68-0.94). The finding did not vary substantially by time from enrolment to diagnosis, and did not change after adjustment for biomarkers of pre-existing liver damage, nor chronic infection with hepatitis B or C viruses. The findings were not modified by body size or smoking status. Conclusion: In this prospective study on Western European populations, serum levels of 25(OH)D were inversely associated with risk of hepatocellular carcinoma. Given the rising incidence of this cancer in low-risk developed countries and the strong public health interest surrounding the potentially cancer-protective roles of vitamin D, additional studies in different populations are required. (Hepatology 2014;).
- Published
- 2013
28. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in s
- Author
-
Fedirko, V., Lukanova, A., Bamia, C., Trichopolou, A., Trepo, E., Nöthlings, U., Schlesinger, S., Aleksandrova, K., Boffetta, P., Tjønneland, A., Johnsen, N. F., Overvad, K., Fagherazzi, G., Racine, A., Boutron-Ruault, M. C., Grote, V., Kaaks, R., Boeing, H., Naska, A., Adarakis, G., Valanou, E., Palli, D., Sieri, S., Tumino, R., Vineis, P., Panico, S., Bueno-de-mesquita, H. B., Siersema, P. D., Peeters, P. H., Weiderpass, E., Skeie, G., Engeset, D., Quirós, J. R., Zamora-Ros, R., Sánchez, M. J., Amiano, P., Huerta, J. M., Barricarte, A., Johansen, D., Lindkvist, B., Sund, M., Werner, M., Crowe, F., Khaw, K. T., Ferrari, P., Romieu, I., Chuang, S. C., Riboli, E., Jenab, M., Fedirko, V., Lukanova, A., Bamia, C., Trichopolou, A., Trepo, E., Nöthlings, U., Schlesinger, S., Aleksandrova, K., Boffetta, P., Tjønneland, A., Johnsen, N.F., Overvad, K., Fagherazzi, G., Racine, A., Boutron-Ruault, M.C., Grote, V., Kaaks, R., Boeing, H., Naska, A., Adarakis, G., Valanou, E., Palli, D., Sieri, S., Tumino, R., Vineis, P., Panico, S., Bueno-de-mesquita, H.B., Siersema, P.D., Peeters, P.H., Weiderpass, E., Skeie, G., Engeset, D., Quirós, J.R., Zamora-Ros, R., Sánchez, M.J., Amiano, P., Huerta, J.M., Barricarte, A., Johansen, D., Lindkvist, B., Sund, M., Werner, M., Crowe, F., Khaw, K.T., Ferrari, P., Romieu, I., Chuang, S.C., Riboli, E., and Jenab, M.
- Subjects
biliary tract neoplasms, dietary carbohydrate, dietary fiber, glycemic index, hepatocellular carcinoma, liver neoplasms - Abstract
Background: The type and quantity of dietary carbohydrate as quantified by glycemic index (GI) and glycemic load (GL), and dietary fiber may influence the risk of liver and biliary tract cancers, but convincing evidence is lacking. Patients and methods: The association between dietary GI/GL and carbohydrate intake with hepatocellular carcinoma (HCC; N = 191), intrahepatic bile duct (IBD; N = 66), and biliary tract (N = 236) cancer risk was investigated in 477 206 participants of the European Prospective Investigation into Cancer and Nutrition cohort. Dietary intake was assessed by country-specific, validated dietary questionnaires. Hazard ratios and 95% confidence intervals were estimated from proportional hazard models. HBV/HCV status was measured in a nested case-control subset. Results: Higher dietary GI, GL, or increased intake of total carbohydrate was not associated with liver or biliary tract cancer risk. For HCC, divergent risk estimates were observed for total sugar = 1.43 (1.17-1.74) per 50 g/day, total starch = 0.70 (0.55-0.90) per 50 g/day, and total dietary fiber = 0.70 (0.52-0.93) per 10 g/day. The findings for dietary fiber were confirmed among HBV/HCV-free participants [0.48 (0.23-1.01)]. Similar associations were observed for IBD [dietary fiber = 0.59 (0.37-0.99) per 10 g/day], but not biliary tract cancer. Conclusions: Findings suggest that higher consumption of dietary fiber and lower consumption of total sugars are associated with lower HCC risk. In addition, high dietary fiber intake could be associated with lower IBD cancer risk. © The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
- Published
- 2013
29. Dietary total antioxidant capacity and gastriccancer risk in the European prospective investigation into cancer and nutritionstudy
- Author
-
Serafini M, Jakszyn P, Luján L, Agudo A, Bas Bueno de Mesquita H, van Duijnhoven FJ, Jenab M, Navarro C, Palli D, Boeing H, Wallström P, Regnér S, Numans ME, Carneiro F, Boutron Ruault MC, Clavel Chapelon F, Morois S, Grioni S, Tumino R, Sacerdote C, Ramon Quirós J, Molina Montes E, Huerta Castaño JM, Barricarte A, Amiano P, Khaw KT, Wareham N, Allen NE, Key TJ, Jeurnink SM, Peeters PH, Bamia C, Valanou E, Trichopoulou A, Kaaks R, Lukanova A, Bergmann MM, Lindkvist B, Stenling R, Johansson I, Dahm CC, Overvad K, Jensen M, Olsen A, Tjonneland A, Bakken K, Dumeaux V, Lund E, McCormack V, Rinaldi S, Michaud D, Mouw T, Riboli E, González C.A., PANICO, SALVATORE, Serafini, M, Jakszyn, P, Luján, L, Agudo, A, Bas Bueno de Mesquita, H, van Duijnhoven, Fj, Jenab, M, Navarro, C, Palli, D, Boeing, H, Wallström, P, Regnér, S, Numans, Me, Carneiro, F, Boutron Ruault, Mc, Clavel Chapelon, F, Morois, S, Grioni, S, Panico, Salvatore, Tumino, R, Sacerdote, C, Ramon Quirós, J, Molina Montes, E, Huerta Castaño, Jm, Barricarte, A, Amiano, P, Khaw, Kt, Wareham, N, Allen, Ne, Key, Tj, Jeurnink, Sm, Peeters, Ph, Bamia, C, Valanou, E, Trichopoulou, A, Kaaks, R, Lukanova, A, Bergmann, Mm, Lindkvist, B, Stenling, R, Johansson, I, Dahm, Cc, Overvad, K, Jensen, M, Olsen, A, Tjonneland, A, Bakken, K, Dumeaux, V, Lund, E, Mccormack, V, Rinaldi, S, Michaud, D, Mouw, T, Riboli, E, and González, C. A.
- Published
- 2012
30. Diabetes mellitus, glycatedhaemoglobin and C-peptide levels in relation to pancreatic cancer risk: a studywithin the European Prospective Investigation into Cancer and Nutrition (EPIC)cohort
- Author
-
Grote VA, Rohrmann S, Nieters A, Dossus L, Tjønneland A, Halkjær J, Overvad K, Fagherazzi G, Boutron Ruault MC, Morois S, Teucher B, Becker S, Sluik D, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Rodríguez L, Duell EJ, Molina Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink SM, Beulens JW, Peeters PH, Sund M, Ye W, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen N, Crowe F, Jenab M, Romieu I, Michaud DS, Riboli E, Romaguera D, Bueno de Mesquita HB, Kaaks R., PANICO, SALVATORE, Grote, Va, Rohrmann, S, Nieters, A, Dossus, L, Tjønneland, A, Halkjær, J, Overvad, K, Fagherazzi, G, Boutron Ruault, Mc, Morois, S, Teucher, B, Becker, S, Sluik, D, Boeing, H, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Palli, D, Pala, V, Tumino, R, Vineis, P, Panico, Salvatore, Rodríguez, L, Duell, Ej, Molina Montes, E, Dorronsoro, M, Huerta, Jm, Ardanaz, E, Jeurnink, Sm, Beulens, Jw, Peeters, Ph, Sund, M, Ye, W, Lindkvist, B, Johansen, D, Khaw, Kt, Wareham, N, Allen, N, Crowe, F, Jenab, M, Romieu, I, Michaud, D, Riboli, E, Romaguera, D, Bueno de Mesquita, Hb, and Kaaks, R.
- Published
- 2011
31. Hepatocellularcarcinoma risk factors and disease burden in a European cohort: a nestedcase-control study
- Author
-
Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Tumino R, Sacerdote C, Bueno De Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E., PANICO, SALVATORE, Trichopoulos, D, Bamia, C, Lagiou, P, Fedirko, V, Trepo, E, Jenab, M, Pischon, T, Nöthlings, U, Overved, K, Tjønneland, A, Outzen, M, Clavel Chapelon, F, Kaaks, R, Lukanova, A, Boeing, H, Aleksandrova, K, Benetou, V, Zylis, D, Palli, D, Pala, V, Panico, Salvatore, Tumino, R, Sacerdote, C, Bueno De Mesquita, Hb, Van Kranen, Hj, Peeters, Ph, Lund, E, Quirós, Jr, González, Ca, Sanchez Perez, Mj, Navarro, C, Dorronsoro, M, Barricarte, A, Lindkvist, B, Regnér, S, Werner, M, Hallmans, G, Khaw, Kt, Wareham, N, Key, T, Romieu, I, Chuang, Sc, Murphy, N, Boffetta, P, Trichopoulou, A, and Riboli, E.
- Published
- 2011
32. Dietary intake of heme iron and risk of gastriccancer in the European prospective investigation into cancer and nutrition(EURGAST- EPIC) study
- Author
-
Jakszyn P, Agudo A, Lujan Barroso L, Bueno de Mesquita HB, Jenab M, Navarro C, Palli D, Boeing H, Manjer J, Numans ME, Igali L, Boutron Ruault MC, Clavel Chapelon F, Morois S, Grioni S, Tumino R, Sacerdote C, Quirós JR, Molina Montes E, Castaño JM, Barricarte A, Amiano P, Khaw KT, Wareham N, Allen NE, Key TJ, Jeurnink SM, Peeters PH, Bamia C, Valanou E, Trichopoulou A, Kaaks R, Lukanova A, Bergmann MM, Lindkvist B, Stenling R, Johansson I, Dahm CC, Overvad K, Olsen A, Tjonneland A, Skeie G, Broderstad AR, Lund E, Michaud DS, Mouw T, Riboli E, González C.A., PANICO, SALVATORE, Jakszyn, P, Agudo, A, Lujan Barroso, L, Bueno de Mesquita, Hb, Jenab, M, Navarro, C, Palli, D, Boeing, H, Manjer, J, Numans, Me, Igali, L, Boutron Ruault, Mc, Clavel Chapelon, F, Morois, S, Grioni, S, Panico, Salvatore, Tumino, R, Sacerdote, C, Quirós, Jr, Molina Montes, E, Castaño, Jm, Barricarte, A, Amiano, P, Khaw, Kt, Wareham, N, Allen, Ne, Key, Tj, Jeurnink, Sm, Peeters, Ph, Bamia, C, Valanou, E, Trichopoulou, A, Kaaks, R, Lukanova, A, Bergmann, Mm, Lindkvist, B, Stenling, R, Johansson, I, Dahm, Cc, Overvad, K, Olsen, A, Tjonneland, A, Skeie, G, Broderstad, Ar, Lund, E, Michaud, D, Mouw, T, Riboli, E, and González, C. A.
- Published
- 2011
33. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigationinto Cancer and Nutrition
- Author
-
Vrieling A, Bueno de Mesquita HB, Boshuizen HC, Michaud DS, Severinsen MT, Overvad K, Olsen A, Tjønneland A, Clavel Chapelon F, Boutron Ruault MC, Kaaks R, Rohrmann S, Boeing H, Nöthlings U, Trichopoulou A, Moutsiou E, Dilis V, Palli D, Krogh V, Tumino R, Vineis P, van Gils CH, Peeters PH, Lund E, Gram IT, Rodríguez L, Agudo A, Larrañaga N, Sánchez MJ, Navarro C, Barricarte A, Manjer J, Lindkvist B, Sund M, Ye W, Bingham S, Khaw KT, Roddam A, Key T, Boffetta P, Duell EJ, Jenab M, Gallo V, Riboli E., PANICO, SALVATORE, Vrieling, A, Bueno de Mesquita, Hb, Boshuizen, Hc, Michaud, D, Severinsen, Mt, Overvad, K, Olsen, A, Tjønneland, A, Clavel Chapelon, F, Boutron Ruault, Mc, Kaaks, R, Rohrmann, S, Boeing, H, Nöthlings, U, Trichopoulou, A, Moutsiou, E, Dilis, V, Palli, D, Krogh, V, Panico, Salvatore, Tumino, R, Vineis, P, van Gils, Ch, Peeters, Ph, Lund, E, Gram, It, Rodríguez, L, Agudo, A, Larrañaga, N, Sánchez, Mj, Navarro, C, Barricarte, A, Manjer, J, Lindkvist, B, Sund, M, Ye, W, Bingham, S, Khaw, Kt, Roddam, A, Key, T, Boffetta, P, Duell, Ej, Jenab, M, Gallo, V, and Riboli, E.
- Published
- 2010
34. Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
- Author
-
Zamora-Ros, R. Sacerdote, C. Ricceri, F. Weiderpass, E. and Roswall, N. Buckland, G. St-Jules, D. E. Overvad, K. and Kyro, C. Fagherazzi, G. Kvaskoff, M. Severi, G. and Chang-Claude, J. Kaaks, R. Noethlings, U. Trichopoulou, A. and Naska, A. Trichopoulos, D. Palli, D. Grioni, S. and Mattiello, A. Tumino, R. Gram, I. T. Engeset, D. Huerta, J. M. Molina-Montes, E. Argueelles, M. Amiano, P. and Ardanaz, E. Ericson, U. Lindkvist, B. Nilsson, L. M. and Kiemeney, L. A. Ros, M. Bueno-de-Mesquita, H. B. Peeters, P. H. M. Khaw, K-T Wareham, N. J. Knaze, V. Romieu, I. and Scalbert, A. Brennan, P. Wark, P. Vineis, P. Riboli, E. and Gonzalez, C. A.
- Abstract
Background: There is growing evidence of the protective role of dietary intake of flavonoids and lignans on cancer, but the association with bladder cancer has not been thoroughly investigated in epidemiological studies. We evaluated the association between dietary intakes of total and subclasses of flavonoids and lignans and risk of bladder cancer and its main morphological type, urothelial cell carcinoma (UCC), within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Methods: A cohort of 477 312 men and women mostly aged 35-70 years, were recruited in 10 European countries. At baseline, dietary flavonoid and lignan intakes were estimated using centre-specific validated questionnaires and a food composition database based on the Phenol-Explorer, the UK Food Standards Agency and the US Department of Agriculture databases. Results: During an average of 11 years of follow-up, 1575 new cases of primary bladder cancer were identified, of which 1425 were UCC (classified into aggressive (n = 430) and non-aggressive (n = 413) UCC). No association was found between total flavonoid intake and bladder cancer risk. Among flavonoid subclasses, significant inverse associations with bladder cancer risk were found for intakes of flavonol (hazard ratio comparing fifth with first quintile (HRQ5-Q1) 0.74, 95% confidence interval (CI): 0.61-0.91; P-trend = 0.009) and lignans (HRQ5-Q 10.78, 95% CI: 0.62-0.96; P-trend = 0.046). Similar results were observed for overall UCC and aggressive UCC, but not for non-aggressive UCC. Conclusions: Our study suggests an inverse association between the dietary intakes of flavonols and lignans and risk of bladder cancer, particularly aggressive UCC.
- Published
- 2014
35. PC.01.6 RISK FACTORS FOR THE OCCURRENCE OF SPORADIC PANCREATIC NEUROENDOCRINE TUMOURS: A MULTICENTER EUROPEAN STUDY (EPINET)
- Author
-
Valente, R., primary, Hayes, A., additional, Haugvik, S.P., additional, Hedenström, P., additional, Siuka, D., additional, Maisonneuve, P., additional, Delle Fave, G., additional, Lindkvist, B., additional, and Capurso, G., additional
- Published
- 2016
- Full Text
- View/download PDF
36. The disintegration of nuclei in violent heavy ion interactions at 55A MeV-110A MeV
- Author
-
Jakobsson, B., Jönsson, G., Lindkvist, B., and Oskarsson, A.
- Published
- 1982
- Full Text
- View/download PDF
37. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans
- Author
-
Fedirko, V. Lukanova, A. Bamia, C. Trichopolou, A. and Trepo, E. Noethlings, U. Schlesinger, S. Aleksandrova, K. and Boffetta, P. Tjonneland, A. Johnsen, N. F. Overvad, K. and Fagherazzi, G. Racine, A. Boutron-Ruault, M. C. Grote, V. Kaaks, R. Boeing, H. Naska, A. Adarakis, G. and Valanou, E. Palli, D. Sieri, S. Tumino, R. Vineis, P. and Panico, S. Bueno-de-Mesquita, H. B(as). Siersema, P. D. and Peeters, P. H. Weiderpass, E. Skeie, G. Engeset, D. and Quiros, J. R. Zamora-Ros, R. Sanchez, M. J. Amiano, P. and Huerta, J. M. Barricarte, A. Johansen, D. Lindkvist, B. and Sund, M. Werner, M. Crowe, F. Khaw, K. T. Ferrari, P. and Romieu, I. Chuang, S. C. Riboli, E. Jenab, M.
- Abstract
The type and quantity of dietary carbohydrate as quantified by glycemic index (GI) and glycemic load (GL), and dietary fiber may influence the risk of liver and biliary tract cancers, but convincing evidence is lacking. The association between dietary GI/GL and carbohydrate intake with hepatocellular carcinoma (HCC; N = 191), intrahepatic bile duct (IBD; N = 66), and biliary tract (N = 236) cancer risk was investigated in 477 206 participants of the European Prospective Investigation into Cancer and Nutrition cohort. Dietary intake was assessed by country-specific, validated dietary questionnaires. Hazard ratios and 95% confidence intervals were estimated from proportional hazard models. HBV/HCV status was measured in a nested case-control subset. Higher dietary GI, GL, or increased intake of total carbohydrate was not associated with liver or biliary tract cancer risk. For HCC, divergent risk estimates were observed for total sugar = 1.43 (1.17-1.74) per 50 g/day, total starch = 0.70 (0.55-0.90) per 50 g/day, and total dietary fiber = 0.70 (0.52-0.93) per 10 g/day. The findings for dietary fiber were confirmed among HBV/HCV-free participants [0.48 (0.23-1.01)]. Similar associations were observed for IBD [dietary fiber = 0.59 (0.37-0.99) per 10 g/day], but not biliary tract cancer. Findings suggest that higher consumption of dietary fiber and lower consumption of total sugars are associated with lower HCC risk. In addition, high dietary fiber intake could be associated with lower IBD cancer risk.
- Published
- 2013
38. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- Author
-
Schlesinger, S. Aleksandrova, K. Pischon, T. Jenab, M. and Fedirko, V. Trepo, E. Overvad, K. Roswall, N. and Tjonneland, A. Boutron-Ruault, M. C. Fagherazzi, G. Racine, A. Kaaks, R. Grote, V. A. Boeing, H. Trichopoulou, A. and Pantzalis, M. Kritikou, M. Mattiello, A. Sieri, S. and Sacerdote, C. Palli, D. Tumino, R. Peeters, P. H. and Bueno-de-Mesquita, H. B. Weiderpass, E. Quiros, J. R. and Zamora-Ros, R. Sanchez, M. J. Arriola, L. Ardanaz, E. and Tormo, M. J. Nilsson, P. Lindkvist, B. Sund, M. and Rolandsson, O. Khaw, K. T. Wareham, N. Travis, R. C. and Riboli, E. Noethlings, U.
- Subjects
digestive system diseases - Abstract
Evidence on associations between self-reported diabetes mellitus, diabetes duration, age at diabetes diagnosis, insulin treatment, and risk of biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), independent of general and abdominal obesity is scarce. We conducted a prospective analysis in the EPIC-cohort study among 363 426 participants with self-reported diabetes data. Multivariable adjusted relative risks and 95% confidence intervals were estimated from Cox regression models. In a nested case-control subset, analyses were carried out in HCV/HBV-negative individuals. During 8.5 years of follow-up, 204 BTC cases [including 75 gallbladder cancer (GBC) cases], and 176 HCC cases were identified. Independent of body mass index and waist-to-height ratio diabetes status was associated with higher risk of BTC and HCC [1.77 (1.00-3.13) and 2.17 (1.36-3.47)]. For BTC, the risk seemed to be higher in participants with shorter diabetes duration and those not treated with insulin. Regarding cancer subsites, diabetes was only associated with GBC [2.72 (1.17-6.31)]. The risk for HCC was particularly higher in participants treated with insulin. The results were not appreciably different in HCV/HBV-negative individuals. This study supports the hypothesis that diabetes is a risk factor for BTC (particularly GBC) and HCC. Further research is required to establish whether diabetes treatment or duration is associated with these cancers.
- Published
- 2013
39. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study
- Author
-
Michaud, D.S. Izard, J. Wilhelm-Benartzi, C.S. You, D.-H. Grote, V.A. Tjønneland, A. Dahm, C.C. Overvad, K. Jenab, M. Fedirko, V. Boutron-Ruault, M.C. Clavel-Chapelon, F. Racine, A. Kaaks, R. Boeing, H. Foerster, J. Trichopoulou, A. Lagiou, P. Trichopoulos, D. Sacerdote, C. Sieri, S. Palli, D. Tumino, R. Panico, S. Siersema, P.D. Peeters, P.H.M. Lund, E. Barricarte, A. Huerta, J.-M. Molina-Montes, E. Dorronsoro, M. Ramón Quirós, J. Duell, E.J. Ye, W. Sund, M. Lindkvist, B. Johansen, D. Khaw, K.-T. Wareham, N. Travis, R.C. Vineis, P. Bas Bueno-De-Mesquita, H. Riboli, E.
- Abstract
Objective: Examine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study. Design We measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition study. Analyses were conducted using conditional logistic regression and additionally adjusted for smoking status and body mass index. Results: Individuals with high levels of antibodies against Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria, had a twofold higher risk of pancreatic cancer than individuals with lower levels of these antibodies (OR 2.14; 95% CI 1.05 to 4.36; >200 ng/ml vs ≤200 ng/ml). To explore the association with commensal (non-pathogenic) oral bacteria, we performed a cluster analysis and identified two groups of individuals, based on their antibody profiles. A cluster with overall higher levels of antibodies had a 45% lower risk of pancreatic cancer than a cluster with overall lower levels of antibodies (OR 0.55; 95% CI 0.36 to 0.83). Conclusions: Periodontal disease might increase the risk for pancreatic cancer. Moreover, increased levels of antibodies against specific commensal oral bacteria, which can inhibit growth of pathogenic bacteria, might reduce the risk of pancreatic cancer. Studies are needed to determine whether oral bacteria have direct effects on pancreatic cancer pathogenesis or serve as markers of the immune response.
- Published
- 2013
40. Rocket observations of slow heavy primary nuclei at Kronogård, Sweden
- Author
-
Yagoda, H., Fukui, K., Holeman, E., Kristiansson, K., and Lindkvist, B.
- Published
- 1964
- Full Text
- View/download PDF
41. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition
- Author
-
Jeurnink, S. M. Buchner, F. L. Bueno-de-Mesquita, H. B. and Siersema, P. D. Boshuizen, H. C. Numans, M. E. Dahm, C. C. and Overvad, K. Tjonneland, A. Roswall, N. Clavel-Chapelon, F. Boutron-Ruault, M. C. Morois, S. Kaaks, R. Teucher, B. Boeing, H. Buijsse, B. Trichopoulou, A. Benetou, V. and Zylis, D. Palli, D. Sieri, S. Vineis, P. Tumino, R. and Panico, S. Ocke, M. C. Peeters, P. H. M. Skeie, G. and Brustad, M. Lund, E. Sanchez-Cantalejo, E. Navarro, C. and Amiano, P. Ardanaz, E. Ramon Quiros, J. Hallmans, G. and Johansson, I. Lindkvist, B. Regner, S. Khaw, K. T. and Wareham, N. Key, T. J. Slimani, N. Norat, T. Vergnaud, A. C. Romaguera, D. Gonzalez, C. A.
- Abstract
Diets high in vegetables and fruits have been suggested to be inversely associated with risk of gastric cancer. However, the evidence of the effect of variety of consumption is limited. We therefore investigated whether consumption of a variety of vegetables and fruit is associated with gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition study. Data on food consumption and follow-up on cancer incidence were available for 452,269 participants from 10 European countries. After a mean follow-up of 8.4 years, 475 cases of gastric and esophageal adenocarcinomas (180 noncardia, 185 cardia, gastric esophageal junction and esophagus, 110 not specified) and 98 esophageal squamous cell carcinomas were observed. Diet Diversity Scores were used to quantify the variety in vegetable and fruit consumption. We used multivariable Cox proportional hazard models to calculate risk ratios. Independent from quantity of consumption, variety in the consumption of vegetables and fruit combined and of fruit consumption alone were statistically significantly inversely associated with the risk of esophageal squamous cell carcinoma (continuous hazard ratio per 2 products increment 0.88; 95% CI 0.790.97 and 0.76; 95% CI 0.620.94, respectively) with the latter particularly seen in ever smokers. Variety in vegetable and/or fruit consumption was not associated with risk of gastric and esophageal adenocarcinomas. Independent from quantity of consumption, more variety in vegetable and fruit consumption combined and in fruit consumption alone may decrease the risk of esophageal squamous cell carcinoma. However, residual confounding by lifestyle factors cannot be excluded.
- Published
- 2012
42. The association of circulating adiponectin levels with pancreatic cancer risk: A study within the prospective EPIC cohort
- Author
-
Grote, V.A. Rohrmann, S. Dossus, L. Nieters, A. Halkjær, J. Tjønneland, A. Overvad, K. Stegger, J. Chabbert-Buffet, N. Boutron-Ruault, M.-C. Clavel-Chapelon, F. Teucher, B. Becker, S. Montonen, J. Boeing, H. Trichopoulou, A. Lagiou, P. Trichopoulos, D. Palli, D. Sieri, S. Tumino, R. Vineis, P. Mattiello, A. Argüelles, M. Duell, E.J. Molina-Montes, E. Larrañaga, N. Chirlaque, M.-D. Gurrea, A.B. Jeurnink, S.M. Peeters, P.H.M. Ye, W. Sund, M. Lindkvist, B. Johansen, D. Khaw, K.-T. Wareham, N. Crowe, F.L. Romieu, I. Rinaldi, S. Jenab, M. Romaguera, D. Michaud, D.S. Riboli, E. Bas Bueno-De-Mesquita, H. Kaaks, R.
- Abstract
Excess body weight and type 2 diabetes mellitus, risk factors of pancreatic cancer, are characterized by decreased levels of adiponectin. In addition to anti-inflammatory and anti-proliferative actions, adiponectin has an important role in regulating glucose metabolism, i.e., decreasing circulating blood glucose levels. Prospectively, hyperglycemia has been associated with risk of pancreatic cancer. The aim of this study was to investigate the association of pre-diagnostic adiponectin levels with pancreatic cancer risk. We conducted a case-control study nested within European Prospective Investigation into Cancer and Nutrition. Blood samples of 452 pancreatic cancer cases and 452 individually matched controls were analyzed by immunoassays. Multivariate conditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Overall, adiponectin showed no association with pancreas cancer risk; however, among never smokers, higher circulating levels of adiponectin were associated with a reduction in pancreatic cancer risk (OR = 0.44 [95% CI 0.23-0.82] for highest vs. lowest quartile), whereas among current smokers there was no significant association (OR = 1.59 [95% CI 0.67-3.76] for highest vs. lowest quartile; p-trend = 0.530; p-interaction = 0.309). In our study, lower adiponectin concentrations may be associated with the development of pancreatic cancer among never smokers, whereas the only other prospective study being conducted so far showed a decrease in risk among male smokers. Therefore, further studies are needed to clarify the role of adiponectin in pancreatic cancer development. © 2011 UICC.
- Published
- 2012
43. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
- Author
-
Ferrari, P. McKay, J. D. Jenab, M. Brennan, P. Canzian, F. Vogel, U. Tjonneland, A. Overvad, K. Tolstrup, J. S. and Boutron-Ruault, M-C Clavel-Chapelon, F. Morois, S. and Kaaks, R. Boeing, H. Bergmann, M. Trichopoulou, A. and Katsoulis, M. Trichopoulos, D. Krogh, V. Panico, S. and Sacerdote, C. Palli, D. Tumino, R. Peeters, P. H. van Gils, C. H. Bueno-de-Mesquita, B. Vrieling, A. Lund, E. and Hjartaker, A. Agudo, A. Suarez, L. R. Arriola, L. and Chirlaque, M-D Ardanaz, E. Sanchez, M-J Manjer, J. and Lindkvist, B. Hallmans, G. Palmqvist, R. Allen, N. Key, T. Khaw, K-T Slimani, N. Rinaldi, S. Romieu, I. and Boffetta, P. Romaguera, D. Norat, T. Riboli, E.
- Abstract
BACKGROUND/OBJECTIVES: Heavy alcohol drinking is a risk factor of colorectal cancer (CRC), but little is known on the effect of polymorphisms in the alcohol-metabolizing enzymes, alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) on the alcohol-related risk of CRC in Caucasian populations. SUBJECTS/METHODS: A nested case-control study (1269 cases matched to 2107controls by sex, age, study centre and date of blood collection) was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC) to evaluate the impact of rs1229984 (ADH1B), rs1573496 (ADH7) and rs441 (ALDH2) polymorphisms on CRC risk. Using the wild-type variant of each polymorphism as reference category, CRC risk estimates were calculated using conditional logistic regression, with adjustment for matching factors. RESULTS: Individuals carrying one copy of the rs1229984(A) (ADH1B) allele (fast metabolizers) showed an average daily alcohol intake of 4.3 g per day lower than subjects with two copies of the rs1229984(G) allele (slow metabolizers) (P-diff
- Published
- 2012
44. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
- Author
-
Leenders, M. Chuang, S.-C. Dahm, C.C. Overvad, K. Ueland, P.M. Midttun, O. Vollset, S.E. Tjønneland, A. Halkjær, J. Jenab, M. Clavel-Chapelon, F. Boutron-Ruault, M.-C. Kaaks, R. Canzian, F. Boeing, H. Weikert, C. Trichopoulou, A. Bamia, C. Naska, A. Palli, D. Pala, V. Mattiello, A. Tumino, R. Sacerdote, C. Van Duijnhoven, F.J.B. Peeters, P.H.M. Van Gils, C.H. Lund, E. Rodriguez, L. Duell, E.J. Pérez, M.-J.S. Molina-Montes, E. Castaño, J.M.H. Barricarte, A. Larrañaga, N. Johansen, D. Lindkvist, B. Sund, M. Ye, W. Khaw, K.-T. Wareham, N.J. Michaud, D.S. Riboli, E. Xun, W.W. Allen, N.E. Crowe, F.L. Bueno-De-Mesquita, H.B. Vineis, P.
- Abstract
Smoking is an established risk factor for pancreatic cancer, previously investigated by the means of questionnaires. Using cotinine as a biomarker for tobacco exposure allows more accurate quantitative analyses to be performed. This study on pancreatic cancer, nested within the European Prospective Investigation into Cancer and Nutrition (EPIC cohort), included 146 cases and 146 matched controls. Using liquid chromatography-mass spectrometry, plasma cotinine levels were analyzed on average 8.0 years before cancer onset (5-95% range: 2.8-12.0 years). The relation between plasma cotinine levels and pancreatic cancer was analyzed with conditional logistic regression for different levels of cotinine in a population of never and current smokers. This was also done for the self-reported number of smoked cigarettes per day at baseline. Every increase of 350 nmol/L of plasma cotinine was found to significantly elevate risk of pancreatic cancer [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.11-1.60]. People with a cotinine level over 1187.8 nmol/L, a level comparable to smoking 17 cigarettes per day, have an elevated risk of pancreatic cancer, compared to people with cotinine levels below 55 nmol/L (OR: 3.66, 95% CI: 1.44-9.26). The results for self-reported smoking at baseline also show an increased risk of pancreatic cancer from cigarette smoking based on questionnaire information. People who smoke more than 30 cigarettes per day showed the highest risk compared to never smokers (OR: 4.15, 95% CI: 1.02-16.42). This study is the first to show that plasma cotinine levels are strongly related to pancreatic cancer. Copyright © 2011 UICC.
- Published
- 2012
45. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort
- Author
-
Grote, V. A. Kaaks, R. Nieters, A. Tjonneland, A. and Halkjaer, J. Overvad, K. Nielsen, M. R. Skjelbo and Boutron-Ruault, M. C. Clavel-Chapelon, F. Racine, A. and Teucher, B. Becker, S. Pischon, T. Boeing, H. and Trichopoulou, A. Cassapa, C. Stratigakou, V. Palli, D. and Krogh, V. Tumino, R. Vineis, P. Panico, S. Rodriguez, L. and Duell, E. J. Sanchez, M-J Dorronsoro, M. Navarro, C. and Gurrea, A. B. Siersema, P. D. Peeters, P. H. M. Ye, W. and Sund, M. Lindkvist, B. Johansen, D. Khaw, K-T Wareham, N. Allen, N. E. Travis, R. C. Fedirko, V. Jenab, M. and Michaud, D. S. Chuang, S-C Romaguera, D. Bueno-de-Mesquita, H. B. Rohrmann, S.
- Abstract
BACKGROUND: Established risk factors for pancreatic cancer include smoking, long-standing diabetes, high body fatness, and chronic pancreatitis, all of which can be characterised by aspects of inflammatory processes. However, prospective studies investigating the relation between inflammatory markers and pancreatic cancer risk are scarce. METHODS: We conducted a nested case-control study within the European Prospective Investigation into Cancer and Nutrition, measuring prediagnostic blood levels of C-reactive protein (CRP), interleukin-6 (IL-6), and soluble receptors of tumour necrosis factor-a (sTNF-R1, R2) in 455 pancreatic cancer cases and 455 matched controls. Odds ratios (ORs) were estimated using conditional logistic regression models. RESULTS: None of the inflammatory markers were significantly associated with risk of pancreatic cancer overall, although a borderline significant association was observed for higher circulating sTNF-R2 (crude OR = 1.52 (95% confidence interval (CI) 0.97-2.39), highest vs lowest quartile). In women, however, higher sTNF-R1 levels were significantly associated with risk of pancreatic cancer (crude OR = 1.97 (95% CI 1.02-3.79)). For sTNF-R2, risk associations seemed to be stronger for diabetic individuals and those with a higher BMI. CONCLUSION: Prospectively, CRP and IL-6 do not seem to have a role in our study with respect to risk of pancreatic cancer, whereas sTNF-R1 seemed to be a risk factor in women and sTNF-R2 might be a mediator in the risk relationship between overweight and diabetes with pancreatic cancer. Further large prospective studies are needed to clarify the role of proinflammatory proteins and cytokines in the pathogenesis of exocrine pancreatic cancer. British Journal of Cancer (2012) 106, 1866-1874. doi:10.1038/bjc.2012.172 www.bjcancer.com Published online 26 April 2012 (C) 2012 Cancer Research UK
- Published
- 2012
46. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
- Author
-
Rohrmann, S. Grote, V. A. Becker, S. Rinaldi, S. and Tjonneland, A. Roswall, N. Gronbaek, H. Overvad, K. and Boutron-Ruault, M. C. Clavel-Chapelon, F. Racine, A. and Teucher, B. Boeing, H. Drogan, D. Dilis, V. Lagiou, P. and Trichopoulou, A. Palli, D. Tagliabue, G. Tumino, R. and Vineis, P. Mattiello, A. Rodriguez, L. Duell, E. J. and Molina-Montes, E. Dorronsoro, M. Huerta, J-M Ardanaz, E. and Jeurnink, S. Peeters, P. H. M. Lindkvist, B. Johansen, D. and Sund, M. Ye, W. Khaw, K-T Wareham, N. J. Allen, N. E. Crowe, F. L. Fedirko, V. Jenab, M. Michaud, D. S. and Norat, T. Riboli, E. Bueno-de-Mesquita, H. B. Kaaks, R.
- Abstract
BACKGROUND: Insulin-like growth factors (IGFs) and their binding proteins (BPs) regulate cell differentiation, proliferation and apoptosis, and may have a role in the aetiology of various cancers. Information on their role in pancreatic cancer is limited and was examined here in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. METHODS: Serum concentrations of IGF-I and IGFBP-3 were measured using enzyme-linked immunosorbent assays in 422 cases and 422 controls matched on age, sex, study centre, recruitment date, and time since last meal. Conditional logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounding variables. RESULTS: Neither circulating levels of IGF-I (OR = 1.21, 95% CI 0.75-1.93 for top vs bottom quartile, P-trend 0.301), IGFBP-3 (OR = 1.00, 95% CI 0.66-1.51, P-trend 0.79), nor the molar IGF-I/IGFBP-3 ratio, an indicator of free IGF-I level (OR = 1.22, 95% CI 0.75-1.97, P-trend 0.27), were statistically significantly associated with the risk of pancreatic cancer. In a cross-classification, however, a high concentration of IGF-I with concurrently low levels of IGFBP-3 was related to an increased risk of pancreatic cancer (OR = 1.72, 95% CI 1.05-2.83; P-interaction = 0.154). CONCLUSION: On the basis of these results, circulating levels of components of the IGF axis do not appear to be the risk factors for pancreatic cancer. However, on the basis of the results of a subanalysis, it cannot be excluded that a relatively large amount of IGF-1 together with very low levels of IGFBP-3 might still be associated with an increase in pancreatic cancer risk. British Journal of Cancer (2012) 106, 1004-1010. doi:10.1038/bjc.2012.19 www.bjcancer.com Published online 7 February 2012 (C) 2012 Cancer Research UK
- Published
- 2012
47. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- Author
-
Grote, V. A. Rohrmann, S. Nieters, A. Dossus, L. and Tjonneland, A. Halkjaer, J. Overvad, K. Fagherazzi, G. and Boutron-Ruault, M. C. Morois, S. Teucher, B. Becker, S. and Sluik, D. Boeing, H. Trichopoulou, A. Lagiou, P. and Trichopoulos, D. Palli, D. Pala, V. Tumino, R. Vineis, P. Panico, S. Rodriguez, L. Duell, E. J. Molina-Montes, E. Dorronsoro, M. Huerta, J. M. Ardanaz, E. Jeurnink, S. M. Beulens, J. W. J. Peeters, P. H. M. Sund, M. Ye, W. and Lindkvist, B. Johansen, D. Khaw, K. T. Wareham, N. and Allen, N. Crowe, F. Jenab, M. Romieu, I. Michaud, D. S. and Riboli, E. Romaguera, D. Bueno-de-Mesquita, H. B. Kaaks, R.
- Abstract
Aims/hypothesis There has been long-standing debate about whether diabetes is a causal risk factor for pancreatic cancer or a consequence of tumour development. Prospective epidemiological studies have shown variable relationships between pancreatic cancer risk and blood markers of glucose and insulin metabolism, overall and as a function of lag times between marker measurements (blood donation) and date of tumour diagnosis. Methods Pre-diagnostic levels of HbA(1c) and C-peptide were measured for 466 participants with pancreatic cancer and 466 individually matched controls within the European Prospective Investigation into Cancer and Nutrition. Conditional logistic regression models were used to estimate ORs for pancreatic cancer. Results Pancreatic cancer risk gradually increased with increasing pre-diagnostic HbA(1c) levels up to an OR of 2.42 (95% CI 1.33, 4.39 highest [>= 6.5%, 48 mmol/mol] vs lowest [
- Published
- 2011
48. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort
- Author
-
Gallo, V., Bueno de Mesquita, H.B., Vermeulen, R.C.H., Andersen, P.M., Kyrozis, A., Linseisen, J., Kaaks, R., Allen, N.E., Roddam, A.W., Boshuizen, H.C., Peeters, P.H.M., Palli, D., Mattiello, A., Sieri, S., Tumino, R., Jimenez-Martin, J.M., Diaz, M.J., Suarez, L.R., Trichopoulou, A., Agudo, A., Arriola, L., Barricante-Gurrea, A., Bingham, S., Khaw, K.T., Manjer, J., Lindkvist, B., Overvad, K., Bach, F.W., Tjonneland, A., Olsen, A., Bergmann, M.M., Boeing, H., Clavel-Chapelon, F., Lund, E., Hallmans, G., Middleton, L., Vineis, P., Riboli, E., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, Risk Assessment of Toxic and Immunomodulatory Agents, and Dep IRAS
- Subjects
Adult ,Male ,Questionnaires ,Risk ,medicine.medical_specialty ,International Cooperation ,Cohort Studies ,Sex Factors ,Internal medicine ,medicine ,Humans ,ddc:610 ,Amyotrophic lateral sclerosis ,Risk factor ,Aged ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Mortality rate ,Amyotrophic Lateral Sclerosis ,Smoking ,Age Factors ,Middle Aged ,Former Smoker ,medicine.disease ,European Prospective Investigation into Cancer and Nutrition ,Europe ,Neurology ,Cohort ,Physical therapy ,Female ,Neurology (clinical) ,business ,Cohort study - Abstract
Udgivelsesdato: 2009-Apr OBJECTIVE: Cigarette smoking has been reported as "probable" risk factor for Amyotrophic Lateral Sclerosis (ALS), a poorly understood disease in terms of aetiology. The extensive longitudinal data of the European Prospective Investigation into Cancer and Nutrition (EPIC) were used to evaluate age-specific mortality rates from ALS and the role of cigarette smoking on the risk of dying from ALS. METHODS: A total of 517,890 healthy subjects were included, resulting in 4,591,325 person-years. ALS cases were ascertained through death certificates. Cox hazard models were built to investigate the role of smoking on the risk of ALS, using packs/years and smoking duration to study dose-response. RESULTS: A total of 118 subjects died from ALS, resulting in a crude mortality rate of 2.69 per 100,000/year. Current smokers at recruitment had an almost two-fold increased risk of dying from ALS compared to never smokers (HR = 1.89, 95% C.I. 1.14-3.14), while former smokers at the time of enrollment had a 50% increased risk (HR = 1.48, 95% C.I. 0.94-2.32). The number of years spent smoking increased the risk of ALS (p for trend = 0.002). Those who smoked more than 33 years had more than a two-fold increased risk of ALS compared with never smokers (HR = 2.16, 95% C.I. 1.33-3.53). Conversely, the number of years since quitting smoking was associated with a decreased risk of ALS compared with continuing smoking. INTERPRETATION: These results strongly support the hypothesis of a role of cigarette smoking in aetiology of ALS. We hypothesize that this could occur through lipid peroxidation via formaldehyde exposure.
- Published
- 2009
49. Ethanol intake and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition (EPIC)
- Author
-
Rohrmann, S. Linseisen, J. Vrieling, A. Boffetta, P. Stolzenberg-Solomon, R.Z. Lowenfels, A.B. Jensen, M.K. Overvad, K. Olsen, A. Tjonneland, A. Boutron-Ruault, M.-C. Clavel-Chapelon, F. Fagherazzi, G. Misirli, G. Lagiou, P. Trichopoulou, A. Kaaks, R. Bergmann, M.M. Boeing, H. Bingham, S. Khaw, K.-T. Allen, N. Roddam, A. Palli, D. Pala, V. Panico, S. Tumino, R. Vineis, P. Peeters, P.H.M. Hjartåker, A. Lund, E. Cornejo, M.L.R. Agudo, A. Arriola, L. Sánchez, M.-J. Tormo, M.-J. Barricarte Gurrea, A. Lindkvist, B. Manjer, J. Johansson, I. Ye, W. Slimani, N. Duell, E.J. Jenab, M. Michaud, D.S. Mouw, T. Riboli, E. Bueno-De-Mesquita, H.B.
- Abstract
Objective: To examine the association of baseline and lifetime ethanol intake with cancer of the pancreas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Methods: Included in this analysis were 478,400 subjects, of whom detailed information on the intake of alcoholic beverages at baseline and over lifetime was collected between 1992 and 2000. During a median follow-up time of 8.9 years, 555 non-endocrine pancreatic cancer cases were observed. Multivariate Cox proportional hazard models were used to examine the association of ethanol intake at recruitment and average lifetime ethanol intake and pancreatic cancer adjusting for smoking, height, weight, and history of diabetes. Results: Overall, neither ethanol intake at recruitment (relative risk (RR) = 0.94, 95% confidence interval (CI) 0.69-1.27 comparing 30+ g/d vs. 0.1-4.9 g/d) nor average lifetime ethanol intake (RR = 0.95, 95% CI 0.65-1.39) was associated with pancreatic cancer risk. High lifetime ethanol intake from spirits/liquor at recruitment tended to be associated with a higher risk (RR = 1.40, 95% CI 0.93-2.10 comparing 10+ g/d vs. 0.1-4.9 g/d), but no associations were observed for wine and beer consumption. Conclusion: These results suggest no association of alcohol consumption with the risk of pancreatic cancer. © 2009 Springer Science+Business Media B.V.
- Published
- 2009
50. Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
- Author
-
Zamora-Ros, R, primary, Sacerdote, C, additional, Ricceri, F, additional, Weiderpass, E, additional, Roswall, N, additional, Buckland, G, additional, St-Jules, D E, additional, Overvad, K, additional, Kyrø, C, additional, Fagherazzi, G, additional, Kvaskoff, M, additional, Severi, G, additional, Chang-Claude, J, additional, Kaaks, R, additional, Nöthlings, U, additional, Trichopoulou, A, additional, Naska, A, additional, Trichopoulos, D, additional, Palli, D, additional, Grioni, S, additional, Mattiello, A, additional, Tumino, R, additional, Gram, I T, additional, Engeset, D, additional, Huerta, J M, additional, Molina-Montes, E, additional, Argüelles, M, additional, Amiano, P, additional, Ardanaz, E, additional, Ericson, U, additional, Lindkvist, B, additional, Nilsson, L M, additional, Kiemeney, L A, additional, Ros, M, additional, Bueno-de-Mesquita, H B, additional, Peeters, P H M, additional, Khaw, K-T, additional, Wareham, N J, additional, Knaze, V, additional, Romieu, I, additional, Scalbert, A, additional, Brennan, P, additional, Wark, P, additional, Vineis, P, additional, Riboli, E, additional, and González, C A, additional
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.